Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Nathaniel EliaDepartment of Physiology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1751.ORCID 0000-0002-7552-092X
Marbella QuiñonezDepartment of Physiology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1751.ORCID 0000-0002-0684-9705
Fenfen WuDepartment of Physiology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1751.ORCID 0009-0007-6078-1952
Ekaterina MokhonovaDepartment of Neurology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1751.ORCID 0009-0005-2580-3402
Marino DiFrancoDepartment of Physiology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1751.ORCID 0000-0002-9315-9429
Melissa J SpencerDepartment of Neurology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1751.ORCID 0000-0001-7104-544X
Stephen C CannonDepartment of Physiology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1751.ORCID 0000-0001-8428-3690
Funding
Disease Pathogenesis and Modification for CaV1.1-Associated Hypokalemic Periodic ParalysisR01AR063182 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI STEPHEN C. CANNON · 2012 to 2026
$6.0M
Muscle Cell Biology, Pathophysiology, and TherapeuticsT32AR065972 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Rachelle Hope Crosbie, THOMAS A. RANDO · 2016 to 2026
$3.9M
Pathophysiology of Myotonia and Periodic ParalysisR01AR078198 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CANNON, STEPHEN C. · 2021 to 2025
$2.7M
Training in Molecular, Cellular &Integrative PhysiologyT32GM065823 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TIDBALL, JAMES G · 2003 to 2017
$2.1M
Optogenetic control of skeletal muscle excitabilityR21AR067422 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DI FRANCO, MARINO, VERGARA, JULIO L · 2014 to 2015
$373k
Opto-Electrophysiological Method to Study Human Skeletal Muscle ChannelopathiesR21AR080282 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DI FRANCO, MARINO, SHIEH, PERRY · 2022 to 2023
$360k
HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR063182HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR078198HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR080282HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) T32AR0659972HHS | NIH | National Institute of General Medical Sciences (NIGMS) T32GM065823NIAMS NIH HHS R01 AR063182NIAMS NIH HHS R01 AR078198NIAMS NIH HHS R21 AR067422NIAMS NIH HHS R21 AR080282NIAMS NIH HHS T32 AR065972NIGMS NIH HHS T32 GM065823
6 · The paper itself
Abstract
Andersen-Tawil syndrome (ATS) is an ion channelopathy with variable penetrance for the triad of periodic paralysis, arrhythmia, and dysmorphia. Dominant-negative mutations of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Potassium-sensitive loss of muscle force in the setting of reduced inward rectifier K · full record | OpenQuestion